2m 2m 2m 2m 2m 2m 2m
NUVECTIS PHARMA (NVCT)
NASDAQ
$22.74+$1.21 (+5.65%)
Price as of Aug 03, 2026 11:17 AM EDT- $678.4MMarket Cap
- 216.47%1-Year Change
- BiotechnologyIndustry
NUVECTIS PHARMA (NVCT)
$22.74+$1.21 (+5.65%)
NVCT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $21.52 | ||
Change | -$1.24 (-5.45%) | ||
Open | $23.12 | ||
High | $23.12 | ||
Low | $21.21 | ||
Previous Close | $22.76 | ||
Volume | 158,827 | ||
30-Day Average Volume | 314,488 | ||
1-Week Change | 11.44% | ||
1-Month Change | 17.02% | ||
1-Year Change | 216.47% | ||
3-Year Change | 53.17% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 31.5M | ||
Total Assets | $25.4M | ||
Market Cap | $678.4M | ||
Enterprise Value | $653.3M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$6.0M | ||
Free Cash Flow | -$6.5M | ||
EBIT | -$6.0M | ||
EBITDA | -$6.0M | ||
Net Working Capital | $14.2M | ||
EPS | -$0.26 | ||
Enterprise Value/EBITDA | -108 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 48 | ||
P/E | -83 | ||
PEG | -5 | ||
Price/Free Cash Flow | -104 | ||
Price/Operating Cash Flow | -104 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue